Skip to main navigation
 
  • Information Request
  • Contact
  • Careers
Search
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
    • Contact
  • Pipeline
    • Overview
    • Stress Urinary Incontinence
    • Breast Cancer
    • Prostate Cancer
  • Diseases
    • Overview
    • Stress Urinary Incontinence
    • Breast Cancer
    • Prostate Cancer
  • Science
    • Overview
    • Selective Androgen Receptor Modulator (SARM)
      • SARMs in SUI
      • SARMs in Breast Cancer
    • Selective Androgen Receptor Degrader (SARD)
  • Investors

    Header ir menu

    • Overview
    • News Releases
    • Events & Presentations
    • Financial Reports
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • IRS Form 8937
    • Contact Us
    • Email Alerts

4

Investor Relations

  • Overview
  • News Releases
  • Events & Presentations
  • Financial Reports
    • SEC Filings
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
  • Investor FAQs
  • IRS Form 8937
  • Contact Us
    • Email Alerts

4

SEC Filings

Document Details

Form
4
Filing Date
Oct 2, 2018
Document Date
Oct 1, 2018
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
GTx, Inc.
Issuer
GTX INC /DE/
Filer
HYDE JOSEPH R III

Filing Formats

View HTML
Download PDF
Download DOC

Shareholder Tools

© 2019 GTx, Inc. All Rights Reserved
  • Terms & Conditions
MENU
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
    • Contact
  • Pipeline
    • Overview
    • Breast Cancer
    • Stress Urinary Incontinence
    • Prostate Cancer
    • Idiopathic Pulmonary Fibrosis
  • Diseases
    • Overview
    • Breast Cancer
    • Stress Urinary Incontinence
    • Prostate Cancer
    • Idiopathic Pulmonary Fibrosis
  • Science
    • Overview
    • Selective Androgen Receptor Modulator (SARM)
    • Selective Androgen Receptor Degrader (SARD)
    • Estrogen Receptor Beta Agonist
  • Investors

    Header ir menu

    • Overview
    • News Releases
    • Events & Presentations
    • Financial Reports
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • IRS Form 8937
    • Contact Us
    • Email Alerts